Literature DB >> 22373569

Occurrence of GCH1 gene mutations in a group of Indian dystonia patients.

Tufan Naiya1, Amar K Misra, Arindam Biswas, Shyamal K Das, Kunal Ray, Jharna Ray.   

Abstract

The aim of this study is to examine the role of GCH1 among Indians affected with dopa responsive dystonia (DRD) and early onset Parkinson's disease (EOPD). The patients (n = 76 including 19 DRD and 36 EOPD) and controls (n = 138) were screened for variants in GCH1 by PCR amplification of exons, splice junctions and 1 kb upstream region followed by SSCP and DNA sequencing. Four novel variants (p.Met1Val, p.Val204_205del, IVS3+68A>G, and IVS5-6T>G) were identified in 10 patients but not in the controls. In addition to two nonsynonymous changes, identified in four DRD patients in heterozygous condition, one intronic variant (IVS5-6T>G) could be linked to pathogenesis of the disease since it has the potential of altering the splice site as assessed by in silico analysis. Patients carrying different nonsynonymous variants had remarkable variation in clinical phenotype. Consistent with earlier reports, severity of clinical phenotype and the age of onset varied among family members harboring the same mutation. No mutation was detected in the EOPD patients. Three novel mutations in GCH1 gene have been found and are shown to be associated with variable clinical phenotypes mostly within the spectrum of DRD. The mutations identified represent 15.79% (3/19) of east Indian DRD patient cohort.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22373569     DOI: 10.1007/s00702-012-0777-z

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  32 in total

1.  Levodopa-responsive dystonia. GTP cyclohydrolase I or parkin mutations?

Authors:  J Tassin; A Dürr; A M Bonnet; R Gil; M Vidailhet; C B Lücking; J Y Goas; F Durif; M Abada; B Echenne; J Motte; A Lagueny; L Lacomblez; P Jedynak; B Bartholomé; Y Agid; A Brice
Journal:  Brain       Date:  2000-06       Impact factor: 13.501

2.  Striatal biopterin and tyrosine hydroxylase protein reduction in dopa-responsive dystonia.

Authors:  Y Furukawa; T G Nygaard; M Gütlich; A H Rajput; C Pifl; L DiStefano; L J Chang; K Price; M Shimadzu; O Hornykiewicz; J W Haycock; S J Kish
Journal:  Neurology       Date:  1999-09-22       Impact factor: 9.910

3.  Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene.

Authors:  H Ichinose; T Ohye; E Takahashi; N Seki; T Hori; M Segawa; Y Nomura; K Endo; H Tanaka; S Tsuji
Journal:  Nat Genet       Date:  1994-11       Impact factor: 38.330

Review 4.  Autosomal dominant GTP cyclohydrolase I (AD GCH 1) deficiency (Segawa disease, dystonia 5; DYT 5).

Authors:  Masaya Segawa
Journal:  Chang Gung Med J       Date:  2009 Jan-Feb

5.  Exhaustive analysis of BH4 and dopamine biosynthesis genes in patients with Dopa-responsive dystonia.

Authors:  Fabienne Clot; David Grabli; Cécile Cazeneuve; Emmanuel Roze; Pierre Castelnau; Brigitte Chabrol; Pierre Landrieu; Karine Nguyen; Gérard Ponsot; Myriem Abada; Diane Doummar; Philippe Damier; Roger Gil; Stéphane Thobois; Alana J Ward; Michael Hutchinson; Annick Toutain; Fabienne Picard; Agnès Camuzat; Estelle Fedirko; Chankannira Sân; Delphine Bouteiller; Eric LeGuern; Alexandra Durr; Marie Vidailhet; Alexis Brice
Journal:  Brain       Date:  2009-06-02       Impact factor: 13.501

6.  Wide expressivity variation and high but no gender-related penetrance in two dopa-responsive dystonia families with a novel GCH-I mutation.

Authors:  Antonino Uncini; Maria Vittoria De Angelis; Patrizia Di Fulvio; Michele Ragno; Grazia Annesi; Alessandro Filla; Liborio Stuppia; Domenico Gambi
Journal:  Mov Disord       Date:  2004-10       Impact factor: 10.338

7.  Dopa-responsive dystonia: long-term treatment response and prognosis.

Authors:  T G Nygaard; C D Marsden; S Fahn
Journal:  Neurology       Date:  1991-02       Impact factor: 9.910

8.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

9.  Dopa-responsive dystonia simulating cerebral palsy.

Authors:  T G Nygaard; S P Waran; R A Levine; A B Naini; A M Chutorian
Journal:  Pediatr Neurol       Date:  1994-10       Impact factor: 3.372

10.  Phenotypic heterogeneity of dopa-responsive dystonia in monozygotic twins.

Authors:  H Grötzsch; H Schnorf; M A Morris; I Moix; J Horvath; O Prilipko; P R Burkhard
Journal:  Neurology       Date:  2004-02-24       Impact factor: 9.910

View more
  4 in total

1.  A Compound Heterozygote for GCH1 Mutation Represents a Case of Atypical Dopa-Responsive Dystonia.

Authors:  Subhajit Giri; Tufan Naiya; Shubhrajit Roy; Gautami Das; Gurusidheshwar M Wali; Shyamal Kumar Das; Kunal Ray; Jharna Ray
Journal:  J Mol Neurosci       Date:  2019-03-25       Impact factor: 3.444

Review 2.  Interpretation of mRNA splicing mutations in genetic disease: review of the literature and guidelines for information-theoretical analysis.

Authors:  Natasha Caminsky; Eliseos J Mucaki; Peter K Rogan
Journal:  F1000Res       Date:  2014-11-18

3.  Dopa-Responsive Dystonia in Han Chinese Patients: One Novel Heterozygous Mutation in GTP Cyclohydrolase 1 (GCH1) and Three Known Mutations in TH.

Authors:  Kunfang Yang; Rongrong Yin; Xiaoping Lan; Yuanfeng Zhang; Hongyi Cheng; Simei Wang; Chunmei Wang; Yanfen Lu; Jiaming Xi; Qin Lu; Jianjun Huang; Yucai Chen
Journal:  Med Sci Monit       Date:  2018-02-06

4.  Dopa-responsive dystonia in a ten-year-old girl.

Authors:  Venkatesh Soma; Hussain Sadiq Mohammed; Ebrahim Riyas; Karuppasamy Murugesan
Journal:  J Family Med Prim Care       Date:  2012-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.